HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model
Graphical Abstract: Schematic representation of 3-step HER2-targeted 225Ac-PRIT, 225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenograft, and representative ...